Natural evolution of prostate cancer

Endocrine-Related Cancer

Volumn 3, Issue 3, 1996, Pages 147-155

  Hugosson, J ^a   Aus, G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER STATISTICS; CANCER SURVIVAL; CAUSE OF DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RISK ASSESSMENT;

EID: 0029910048     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0030147     Document Type: Article

References (22)

1. Adolfsson J 1993 Deferred treatment of low grade stage T3 prostate cancer without distant metastases. Journal of Urology 149 326-328.
2. Albertsen PC, Fryback DG, Storer BE, Kolon TF & Fine J 1995 Long-term survival among men with conservatively treated localized prostate cancer. Journal of the American Medical Association 274 626-631.
3. Aus G, Hugosson J & Norlén L 1995a Long-term survival and mortality in prostate cancer treated with noncurative intention. Journal of Urology 154 460-465.
4. Aus G, Hugosson J & Norlén L 1995b Need for hospital care and palliative treatment in prostate cancer treated with non-curative intention. Journal of Urology 154 466-469.
5. Boring CC, Squires TS, Tong T & Montgomery S 1994 Cancer statistics. CA Cancer Journal for Clinicians 44 7-26.
6. Brown ML, Fintor L & Newman-Horm PA 1996 The economic burden of cancer. In The Science and Practice of Cancer Prevention and Control. Eds P Greenwald, B Kramer & D Wed. New York: Marcel Dekker (In Press).
7. Carlsson P 1995. Massundersökning för Prostatacancer, pp 68-70. Stockholm: The Swedish Council on Technology Assessment in Health Care.
8. Carlsson P, Hjertberg H, Jönsson B & Varenhorst E 1989 The cost of prostatic cancer in a defined population. Scandinavian Journal of Urology and Nephrology 23 93-96.
9. Catalona WJ, Smith DS & Ratliff TL 1991 Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine 324 1156-1161.
10. Chodak GW, Thistedt RA, Gerber GS, Johansson JE, Adolfsson J, Jones G, Chisholm GD, Moskovitz B, Livne PM & Warner J 1994 Results of conservative management of clinically localized prostate cancer. New England Journal of Medicine 330 242-248.
11. George N 1988 Natural history of localised prostate cancer managed by conservative therapy alone. Lancet i 494-497.
12. Gibbons RP, Correa RJ, Brannen GE & Weissman RM 1989 Total prostatectomy for clinically localized prostatic cancer: Long term results. Journal of Urology 141 564-566.
13. Grönberg H, Damber J-E, Jonsson H & Lenner P 1994 Patient age as a prognostic factor in prostate cancer 152 892-895.
14. Hakulinen T 1977 On long-term relative survival rates. Journal of Chronic Disease 30 431-443.
15. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L & Krusemo UB 1992 High 10-year survival rate in patients with early, untreated prostatic cancer [see comments]. Journal of the American Medical Association 267 2191-2196.
16. Labrie F, Dupont A & Suburu R 1992 Serum prostatic specific antigen (PSA) as prescreening test for prostate cancer. Journal of Urology 147 846-852.
17. Lepor H, Kimball AW & Walsh PC 1989 Cause-specific actuarial survival analysis: A useful method for reporting survival data in men with clinically localized carcinoma of the prostate. Journal of Urology 141 82-84.
18. Norlén BJ 1991 Survival and mortality in prostate cancer. A study based on the Swedish cancer registry. Acta Oncologica 30 141-144.
19. Otnes B, Harvei S & Fosså SD 1995 The burden of prostate cancer from diagnosis until death. British Journal of Urology 76 587.
20. Stenbeck M & Holm L-E 1994 Male genital organs. In Cancer Survival in Sweden in 1961-1991, pp 61-66. Eds M Stenbeck & M Rosén. Acta Oncologica (Suppl). Oslo, Copenhagen, Stockholm, Boston: Scandinavian University Press.
21. Whitmore WJ, Warner J & Thompson I 1991 Expectant management of palpable clinically localized prostate cancer. Cancer 67 1091-1096.
22. Zincke H, Oesterling JE & Blute ML 1994 Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. Journal of Urology 152 1850.